Drugs that contain Amlodipine Benzoate
1. Katerzia patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10952998 | AZURITY | Amlodipine formulations |
Oct, 2037
(13 years from now) | |
| US11364230 | AZURITY | Amlodipine formulations |
Oct, 2037
(13 years from now) | |
| US11701326 | AZURITY | Amlodipine formulations |
Oct, 2037
(13 years from now) | |
| US10894039 | AZURITY | Amlodipine formulations |
Oct, 2037
(13 years from now) | |
| US11471409 | AZURITY | Amlodipine formulations |
Oct, 2037
(13 years from now) | |
| US10959991 | AZURITY | Amlodipine formulations |
Oct, 2037
(13 years from now) | |
| US11484498 | AZURITY | Amlodipine formulations |
Oct, 2037
(13 years from now) | |
| US10695329 | AZURITY | Amlodipine formulations |
Oct, 2037
(13 years from now) | |
| US10799453 | AZURITY | Amlodipine formulations |
Apr, 2039
(14 years from now) | |
Market Authorisation Date: 08 July, 2019
Treatment: Method of treating hypertension; A method of treating hypertension; Angina
Dosage: SUSPENSION;ORAL
How can I launch a generic of KATERZIA before it's drug patent expiration?
More Information on Dosage
KATERZIA family patents
